In an Alzheimer’s disease model, increased mitochondrial ROS levels lead to a shortening of mitochondria and an increase in Drp1 activation by the phosphorylation process (Cho et al. 2012). This evidence concerns the gene DNM1L and early-onset autosomal dominant Alzheimer disease.